Investor Relations

News

11 January 2021

Jenoptik green-lights plans for modern company restaurant in Jena-Göschwitz

06 January 2021

Leslie Iltgen appointed new Head of Investor Relations & Corporate Communications at Jenoptik

24 November 2020

Innovation in the healthcare and life sciences markets drives new North American business for Jenoptik’s biophotonics group

Last Tick:	18/01/2021 17:35
Last Price:	23,62€
Perf.%:	-0,51
Volume:	86.597
ISIN:	DE000A2NB601
Exchange:	Xetra

Investor Information

Facts and Figures

Jenoptik at a glance for investors — **Jenoptik at a glance**

read more

Share Information for Investors — **Share**

read more

News and Adhoc releases for Investors — **Adhoc releases and IR news**

read more

Corporate Governance at Jenoptik — **Corporate Governance**

read more

**Reports and Presentations**

read more

Annual General Meeting

Quick Info

Next financial dates:

10.02.2021, Preliminary results 2020
25.03.2021, Financial statements 2020

Financial calendar

Investor Relations

+49 3641 65-2156

+49 3641 65-2804

Personal Information

Salutation

Mr.

Ms.

Name *

Company

Country

Phone

E-mail *

Please do not fill in this field.

Your inquiry

Message

I am a Jenoptik customer already.

CustomerNumber

I consent that JENOPTIK AG or the Jenoptik Group company responsible for my request may process my e-mail address and my other personal data entered in the contact form in order to contact me by e-mail, telephone or otherwise and send me information on products and services offered by the Jenoptik Group. I am entitled at any time to receive information on the personal data stored about me and I can request the rectification, erasure or blocking of individual personal data. I can withdraw this declaration of consent at any time without giving reasons. Besides, I took notice of the Data protection declaration on the contact form. *

* = mandatory field, please complete

Investor Relations

News

Jenoptik green-lights plans for modern company restaurant in Jena-Göschwitz

Leslie Iltgen appointed new Head of Investor Relations & Corporate Communications at Jenoptik

Innovation in the healthcare and life sciences markets drives new North American business for Jenoptik’s biophotonics group

Aktien

Facts and Figures

Quick Info

Do you have any questions? Please contact us for advice.

Investor Relations

Personal Information

Your inquiry